Literature DB >> 9104922

Usefulness of preoperative noninvasive radionuclide testing for detecting coronary artery disease in candidates for liver transplantation.

V A Kryzhanovski1, G A Beller.   

Abstract

This study, conducted in 87 candidates for liver transplantation, shows that neither stress perfusion imaging nor rest radionuclide ventriculography appear useful for preoperative cardiac risk assessment because most patients have normal studies and a favorable outcome. Routine myocardial function testing "to rule out cardiomyopathy" in asymptomatic (from a cardiac standpoint) patients with end-stage alcoholic liver disease should be abandoned.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9104922     DOI: 10.1016/s0002-9149(97)00030-1

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  10 in total

1.  The role of radionuclide myocardial perfusion imaging for asymptomatic individuals.

Authors:  Robert C Hendel; Brian G Abbott; Timothy M Bateman; Ron Blankstein; Dennis A Calnon; Jeffrey A Leppo; Jamshid Maddahi; Matthew M Schumaecker; Leslee J Shaw; R Parker Ward; David G Wolinsky
Journal:  J Nucl Cardiol       Date:  2011-02       Impact factor: 5.952

Review 2.  Cardiac evaluation of liver transplant candidates.

Authors:  Mercedes Susan Mandell; Joann Lindenfeld; Mei-Yung Tsou; Michael Zimmerman
Journal:  World J Gastroenterol       Date:  2008-06-14       Impact factor: 5.742

Review 3.  The question: to test or not to test in preoperative cardiac risk evaluation.

Authors:  J A Leppo; S T Dahlberg
Journal:  J Nucl Cardiol       Date:  1998 May-Jun       Impact factor: 5.952

Review 4.  Role of cardiovascular intervention as a bridge to liver transplantation.

Authors:  Zankhana Raval; Matthew E Harinstein; James D Flaherty
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

5.  Liver transplantation for alcoholic liver disease.

Authors:  Vibha Varma; Kerry Webb; Darius F Mirza
Journal:  World J Gastroenterol       Date:  2010-09-21       Impact factor: 5.742

6.  Safety of regadenoson in patients with end-stage liver disease.

Authors:  Wael Aljaroudi; Fahad Iqbal; Jayanth Koneru; Pradeep Bhambhvani; Jaekyeong Heo; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2010-09-18       Impact factor: 5.952

7.  Prevalence of myocardial perfusion abnormalities in end-stage liver disease.

Authors:  Ahmed Fathala; Bander Safar; Ahmed Al Muhaideb
Journal:  Indian J Nucl Med       Date:  2011-01

8.  Significance of Abnormal Myocardial Perfusion Scans in Candidates for Orthotopic Liver Transplantation.

Authors:  Atefe Esmaili; Saeed Farzanefar; Alireza Emami-Ardakani; Mehrshad Abbasi
Journal:  J Tehran Heart Cent       Date:  2017-01

9.  Cardiac stress testing and coronary artery disease in liver transplantation candidates: Meta-analysis.

Authors:  Jonathan Soldera; Fábio Camazzola; Santiago Rodríguez; Ajacio Brandão
Journal:  World J Hepatol       Date:  2018-11-27

10.  Coronary Computed Tomography Angiography Demonstrates a High Burden of Coronary Artery Disease Despite Low-Risk Nuclear Studies in Pre-Liver Transplant Evaluation.

Authors:  Adrián I Löffler; Jorge A Gonzalez; Shriram K Sundararaman; Roshin C Mathew; Patrick T Norton; Klaus D Hagspiel; Christopher M Kramer; Michael Ragosta; Campbell Rogers; Neeral L Shah; Michael Salerno
Journal:  Liver Transpl       Date:  2020-11       Impact factor: 5.799

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.